Header cover image

Japanese Pharmaceuticals & Biotech Your first investment

Results

9

1 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

9 companies

Chugai Pharmaceutical

Market Cap: JP¥11.5t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

New

4519

JP¥7,061.00

7D

-3.4%

1Y

-4.7%

Otsuka Holdings

Market Cap: JP¥6.0t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥11,510.00

7D

4.9%

1Y

59.1%

Astellas Pharma

Market Cap: JP¥4.0t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,295.50

7D

5.5%

1Y

54.3%

Shionogi

Market Cap: JP¥2.5t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

4507

JP¥3,064.00

7D

6.5%

1Y

21.2%

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

4151

JP¥2,697.00

7D

2.7%

1Y

5.1%

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥2,509.00

7D

4.3%

1Y

50.6%

Santen Pharmaceutical

Market Cap: JP¥630.5b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

4536

JP¥2,029.00

7D

2.1%

1Y

22.0%

Tsumura

Market Cap: JP¥292.9b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

4540

JP¥4,039.00

7D

4.6%

1Y

9.8%

Nippon Shinyaku

Market Cap: JP¥241.3b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

4516

JP¥3,552.00

7D

-11.6%

1Y

9.8%